Delirium after interleukin-2 and alpha-interferon therapy for renal cell carcinoma

被引：0
|
作者：
Van Steijn, JHM [1 ]
Nieboer, P [1 ]
Hospers, GAP [1 ]
De Vries, EGE [1 ]
Mulder, NH [1 ]
机构：
[1] Univ Groningen Hosp, Dept Med Oncol, Groningen, Netherlands
来源：
ANTICANCER RESEARCH | 2001年 / 21卷 / 05期
关键词：
alpha-nterferon; central nervous svstem; interleukin-2; renal cell carcinoma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A 55-year-old man receiving alpha-interferon and interieukin-2 therapy for renal cell carcinoma presented with seizures and delirium. A CT-scan of the cerebrum did not reveal any disorder. Both alpha-interferon and interleukin-2 were stopped Treatment with steroids led to complete regression of central nervous system symptomatology. We emphasize the importance of ruling out iatrogenesis in patients treated with alpha-interferon and/or interleukin-2 who display neuropsychiatric symptoms.
引用
收藏
页码：3699 / 3700
页数：2
相关论文
共 50 条
  • [1] LOW-DOSE CYCLOPHOSPHAMIDE, ALPHA-INTERFERON AND CONTINUOUS INFUSIONS OF INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA
    WERSALL, JP
    MASUCCI, G
    HJELM, AL
    RAGNHAMMAR, P
    FAGERBERG, J
    FRODIN, JE
    MERK, K
    LINDEMALM, C
    ERICSON, K
    KALIN, B
    MELLSTEDT, H
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1993, 10 (03): : 103 - 111
  • [2] INTERLEUKIN-2 AND INTERFERON-ALPHA-2A OUTPATIENT THERAPY FOR METASTATIC RENAL-CELL CARCINOMA
    LIPTON, A
    HARVEY, H
    GIVANT, E
    HOPPER, K
    LAWLER, J
    MATTHEWS, Y
    HIRSH, M
    ZEFFREN, J
    JOURNAL OF IMMUNOTHERAPY, 1993, 13 (02) : 122 - 129
  • [3] INTERLEUKIN-2 AND INTERFERON IN RENAL-CELL CARCINOMA
    WERSALL, P
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1993, 10 (1-2): : 71 - 76
  • [4] RECOMBINANT INTERFERON-ALPHA-2A AND INTERLEUKIN-2 IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    JURINCICWINKLER, C
    HORLBECK, R
    KLIPPEL, KF
    WIENER KLINISCHE WOCHENSCHRIFT, 1993, 105 (10) : 271 - 276
  • [5] INTENSIVE RECOMBINANT INTERLEUKIN-2 AND ALPHA-INTERFERON THERAPY IN PATIENTS WITH ADVANCED HEAD AND NECK SQUAMOUS CARCINOMA
    URBA, SG
    FORASTIERE, AA
    WOLF, GT
    AMREIN, PC
    CANCER, 1993, 71 (07) : 2326 - 2331
  • [6] CEREBRAL VASCULITIS AFTER INTERLEUKIN-2 THERAPY FOR RENAL-CELL CARCINOMA
    MICHEL, M
    VINCENT, F
    SIGAL, R
    DAMAJ, G
    BENSOUSAN, TA
    LECLERCQ, B
    ESCUDIER, B
    JOURNAL OF IMMUNOTHERAPY, 1995, 18 (02): : 124 - 126
  • [7] RENAL-CELL CARCINOMA WITH SUBCUTANEOUS INJECTIONS OF INTERLEUKIN-2 AND INTERFERON-ALPHA
    HOFMOCKEL, G
    THEISS, M
    BUSSEN, D
    WIRTH, MP
    FROHMULLER, HGW
    UROLOGE-AUSGABE A, 1994, 33 (05): : 434 - 439
  • [8] TREATMENT OF ADVANCED RENAL-CELL CANCER WITH SEQUENTIAL INTRAVENOUS RECOMBINANT INTERLEUKIN-2 AND SUBCUTANEOUS ALPHA-INTERFERON
    BESANA, C
    BORRI, A
    BUCCI, E
    CITTERIO, G
    DILUCCA, G
    FORTIS, C
    MATTEUCCI, P
    TOGNELLA, S
    TRESOLDI, M
    BAIOCCHI, C
    LANDONIO, G
    GHISLANDI, E
    RUGARLI, C
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) : 1292 - 1298
  • [9] Interleukin-2, interferon-α and interleukin-2 plus interferon-α in renal cell carcinoma.: A randomized phase II trial
    Boccardo, F
    Rubagotti, A
    Canobbio, L
    Galligioni, E
    Sorio, R
    Lucenti, A
    Cognetti, F
    Ruggeri, E
    Landonio, G
    Baiocchi, C
    Besana, C
    Citterio, G
    De Rosa, M
    Calabresi, F
    TUMORI, 1998, 84 (05) : 534 - 539
  • [10] Subcutaneous interleukin-2 and interferon in the treatment of patients with metastatic renal cell carcinoma -: Less efficacy compared with intravenous interleukin-2 and interferon α
    Ravaud, A
    Delva, R
    Gomez, F
    Chevreau, C
    Douillard, JY
    Peny, J
    Coudert, B
    Négrier, S
    CANCER, 2002, 95 (11) : 2324 - 2330
12345